One more arrest in JK spurious drug scam

Image
Press Trust of India Jammu
Last Updated : Apr 27 2013 | 8:40 PM IST
With the arrest of one more person today, the total number of accused held in connection with the supply and purchase of spurious drugs in Jammu and Kashmir that triggered protests in the Valley, rose to four.
"The Crime Branch sleuths succeeded in procuring the custody of the third accused Akhil Gadoo when he surrendered and approached the Jammu court of special judge, anti- corruption, to seek bail," a senior police officer said here.
The court kept the application for consideration and handed over the custody of the accused to the Jammu Crime Branch, he said.
Gadoo was evading arrest for the past few days.
"His questioning is expected to yield important clues and links necessary for the investigation of the case," the officer said.
Police teams have been dispatched to neighbouring states to identify and apprehend the other accused and seize relevant records, he said.
On April 21, Crime Branch arrested brother-duo Amardeep and Ashok Raina from New Delhi and Jammu.
A case regarding supply and purchase of spurious drugs in Jammu and Kashmir was registered in January 20.
An inquiry committee, set up by the state government on April 4, had given clean chit to former health minister Sham Lal Sharma (currently PHE, Irrigation and Flood Control Minister) in the case pertaining to supply of Rs 11.32 lakh spurious drugs 'Amoxicillin Trihydrate' to the JK government.
It ordered a probe by Crime Branch and Vigilance Organisation against the proprietors of Life Line Pharmaco Surgicals and officers of purchase committee-II of Medical Education department in the case.
According to the report submitted by the committee, owners of Life Line Pharmaco Surgicals flouted government norms while participating in the tendering process.
The report said the company produced fake authorisation certificate purportedly issued by Medley Pharmaceuticals Ltd. However, during the course of enquiry, it came to light that Medley Pharmaceuticals Ltd had not issued any authorisation to Life Line Pharmaco Surgicals and the owners of Life Line Pharmaco Surgicals had entered into the tendering process and supply of drugs by producing fake and fabricated authorisation certificate.
The company supplied spurious drugs in connivance with officials of the Purchase Committee-II, who without verifying the tender documents and credentials of the supplier, approved the rates by abusing their official position, causing wrongful gain to suppliers and huge loss to public exchequer.
"Some incriminating documents and material have been recovered and seized. Preliminary investigations have revealed that these drugs were manufactured in a factory outside the state," the officer said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 27 2013 | 8:40 PM IST

Next Story